Axsome Therapeutics AXSM
NASDAQ AXSM
$179.25 -2.82 (-1.55%)
At close: Oct 2, 2026 · 4:00 PM EDT

Axsome Therapeutics (AXSM) Return on Assets [ROA] (2016 - 2026)

Updated

Axsome Therapeutics (AXSM) recorded Return on Assets [ROA] of -25.99% in Q2 2026, up 13.94 percentage points from -39.93% a year earlier and up 0.84 percentage points from the prior quarter.

Analysis

Axsome Therapeutics (AXSM) Return on Assets [ROA] (2016 - 2026) Analysis & Trends

For FY2025, Axsome Therapeutics reported Return on Assets [ROA] of -29.11%, up 20.55 percentage points from FY2024.

  • Annual Return on Assets [ROA] has increased for four straight years, with a five-year change of +20.90 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Assets [ROA] came in at -49.66% in FY2024 (+2.36 pp), -52.02% in FY2023 (+37.24 pp), -89.27% in FY2022 (+5.94 pp) and -95.21% in FY2021 (-45.19 pp).
  • The Q2 2026 figure is the highest quarterly Return on Assets [ROA] since Q2 2018.
  • On a year-over-year basis, Return on Assets [ROA] has increased for six consecutive quarters, with an average year-over-year change of +8.42 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 115.60 percentage points in Q1 2023, against a drop of 103.87 percentage points in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -26.84% (Q1 2026), -26.96% (Q4 2025) and -35.06% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 10.47%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 4.65%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 28.37%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.10%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 9.29%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -6.13%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 2.14%
10 Axsome Therapeutics 9.52 Bn 8.25 Bn 204.81 Mn -25.99%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -25.99%
Mar 31, 2026 -26.84%
Dec 31, 2025 -26.96%
Sep 30, 2025 -35.06%
Jun 30, 2025 -39.93%
Mar 31, 2025 -47.77%
Dec 31, 2024 -50.84%
Sep 30, 2024 -56.04%
Jun 30, 2024 -56.40%
Mar 31, 2024 -52.27%
Dec 31, 2023 -40.24%
Sep 30, 2023 -33.29%
Jun 30, 2023 -36.86%
Mar 31, 2023 -44.05%
Dec 31, 2022 -55.82%
Sep 30, 2022 -61.55%
Jun 30, 2022 -111.42%
Mar 31, 2022 -159.66%
Dec 31, 2021 -127.61%
Sep 30, 2021 -96.70%
API Access

Axsome Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=AXSM&period=max&api_key=YOUR_API_KEY